NLRP3 and obesity due to melanocortin 4 receptor deficiency: Obesity increases the risk of endometrial cancer (134), and the NLRP3-IL-1β pathway plays a crucial role in adipose tissue (AT)-induced inflammation and the development of obesity-related comorbidities.